Trials / Recruiting
RecruitingNCT05288699
Mobile App for Latinx Hazardous Drinkers With Clinical Anxiety
Brief Personalized Feedback Intervention for Latinx Hazardous Drinkers: A Community-Based Intervention
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Michael J. Zvolensky, Ph.D. · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to develop and examine a culturally adapted, brief, integrated, Spanish language mobile health application for the Android platform, optimized to deliver a personalized feedback intervention (PFI) designed to enhance knowledge regarding adverse anxiety-alcohol interrelations, increase motivation and intention to reduce hazardous drinking, and reduce positive attitudes and intention regarding anxiety-related alcohol use among Latinx hazardous drinkers with clinical anxiety.
Detailed description
Investigators will develop a culturally adapted, brief, single-session, Spanish language, PFI delivered via a mobile health application for the Android platform through an iterative approach using expert input and focus groups. Next, Latinx hazardous drinkers with clinical anxiety will assess program navigation and conduct usability testing. Finally, Latinx hazardous drinkers with clinical anxiety will be recruited to complete the final prototype of the mobile health application in order to evaluate the feasibility, acceptability, and initial effects. Initial screening will be conducted via telephone; baseline and post-treatment data will be collected in-person; and 1-week, 1-month, and 3-months follow-up data will be collected remotely.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Aliento | Aliento is a culturally adapted, brief, personalized feedback intervention (PFI) to address alcohol misuse in the context of clinical anxiety delivered via a mobile application. |
Timeline
- Start date
- 2022-11-04
- Primary completion
- 2025-02-28
- Completion
- 2025-04-30
- First posted
- 2022-03-21
- Last updated
- 2024-05-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05288699. Inclusion in this directory is not an endorsement.